Author:
Park Jangho,Lee Kwang-Woong,Oh Seung Cheol,Park Min Young,Lee Jeong-Moo,Hong Su Young,Hong Suk Kyun,Choi YoungRok,Yi Nam-Joon,Suh Kyung-Suk
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Barbarino JM, Staatz CE, Venkataramanan R, Klein TE, Altman RB. PharmGKB summary: cyclosporine and tacrolimus pathways. Pharmacogenet Genom 2013;23:563–585
2. Staatz CE, Goodman LK, Tett SE. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Clin Pharmacokinet 2010;49:141–175
3. Kato H, Usui M, Muraki Y, Tanemura A, Murata Y, Kuriyama N, et al. Long-term influence of CYP3A5 gene polymorphism on pharmacokinetics of tacrolimus and patient outcome after living donor liver transplantation. Transpl Proc 2016;2016(48):1087–1094
4. Debette-Gratien M, Woillard JB, Picard N, Sebagh M, Loustaud-Ratti V, Sautereau D, et al. Influence of donor and recipient CYP3A4, CYP3A5, and ABCB1 genotypes on clinical outcomes and nephrotoxicity in liver transplant recipients. Transplantation 2016;2016(100):2129–2137
5. Buendía JA, Otamendi E, Kravetz MC, Cairo F, Ruf A, de Davila M, et al. Combinational effect of CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics in liver transplant patients. Exp Clin Transpl 2015;2015(13):441–448
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献